-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, the pace of Chinese medicine going out has been accelerating
.
According to statistics, in 2020, the relevant domestic and foreign institutions in the TCM service trade statistics pilot have served a total of 2.
121 million person-times with an income of 570 million yuan; of which, overseas income will exceed 60%
.
It is worth mentioning that while the "going global" of Chinese medicine in overseas markets is accelerating, more and more domestic Chinese medicine companies have begun to make major breakthroughs in overseas exports
.
For example, in January this year, Foci Pharmaceuticals announced that the three products of the classic traditional Chinese medicines Huoxiang Zhengqi Pills, Fangfeng Tongsheng Pills, and Xiao Chaihu Tang Pills have obtained the drug registration certificate issued by the Ministry of Health of Uzbekistan.
It is reported that this is a classic Chinese medicine.
Mingfang's products obtained the Uzbekistan Drug Certificate for the first time
.
In June, Yiling Pharmaceutical received the registration approval document for Lianhua Qingwen Capsules approved and issued by the Ministry of Health of Ukraine; in addition, Hehuang Pharmaceutical’s Danning tablets were also approved for marketing in Canada, becoming the first "functional and indication".
Compound Chinese medicine recognized by regulatory authorities in European and American countries.
.
.
In addition to continuing to be listed overseas, more and more domestic Chinese medicine companies are also accelerating the expansion of the international market through marketing localization
.
For example, Tongrentang Sinopharm, a subsidiary of Tongrentang, has 69 retail terminals covering major countries and regions in Asia, Oceania, North America, and Europe
.
The Baiyun Mountain Huatuozaizao pill has also been sold or registered in 29 countries and territories on six continents, including Russia, Belarus, Ukraine, Georgia, Canada, Ecuador, New Zealand, Thailand and Vietnam
.
The industry believes that these products have accelerated and successfully launched in overseas markets, marking a key breakthrough in the internationalization of Chinese medicine, and Chinese medicine companies have entered the international market
.
However, it should be noted that the industry has also pointed out that with the steady progress of the internationalization of Chinese medicine, there are still many difficulties to be solved
.
For example, China’s current intellectual property legal system is far from meeting the need for protection of intellectual rights in traditional Chinese medicine, and is causing the loss of a large number of intellectual property rights, traditional knowledge and biological resources in traditional Chinese medicine.
.
In addition, in many countries, the clinical application of TCM has not yet obtained a real license.
For example, after some Chinese patent medicines go to the sea, they can only be placed on the shelves of health care products or food additives, and they cannot obtain the identity of medicines
.
In this regard, analysts suggest that in the process of promoting the international development of Chinese medicine, the exchange of talents and the promotion of appropriate technologies should also be strengthened, through the joint training model, so that Chinese medicine talents can be localized in the target country; and joint research projects, Start with botanicals and realize the localization of medicines in target countries
.
In addition, international cooperation can be further promoted by establishing overseas centers, strengthening the promotion of Chinese medicine culture, strengthening scientific research exchanges, establishing dialogue mechanisms, etc.
, and taking multiple measures to gradually deepen overseas recognition and acceptance of Chinese medicine, so as to continuously improve.
The overseas voice of Chinese medicine
.
In general, more and more overseas countries have a substantial increase in the recognition of Chinese medicine.
Although there are still some problems, in the future, domestic Chinese medicine companies and Chinese medicine exchanges and cooperation platforms will continue to expand and have more exchanges.
Under the background of channels, the industry generally believes that traditional Chinese medicine will certainly have huge room for development in overseas markets
.
.
According to statistics, in 2020, the relevant domestic and foreign institutions in the TCM service trade statistics pilot have served a total of 2.
121 million person-times with an income of 570 million yuan; of which, overseas income will exceed 60%
.
It is worth mentioning that while the "going global" of Chinese medicine in overseas markets is accelerating, more and more domestic Chinese medicine companies have begun to make major breakthroughs in overseas exports
.
For example, in January this year, Foci Pharmaceuticals announced that the three products of the classic traditional Chinese medicines Huoxiang Zhengqi Pills, Fangfeng Tongsheng Pills, and Xiao Chaihu Tang Pills have obtained the drug registration certificate issued by the Ministry of Health of Uzbekistan.
It is reported that this is a classic Chinese medicine.
Mingfang's products obtained the Uzbekistan Drug Certificate for the first time
.
In June, Yiling Pharmaceutical received the registration approval document for Lianhua Qingwen Capsules approved and issued by the Ministry of Health of Ukraine; in addition, Hehuang Pharmaceutical’s Danning tablets were also approved for marketing in Canada, becoming the first "functional and indication".
Compound Chinese medicine recognized by regulatory authorities in European and American countries.
.
.
In addition to continuing to be listed overseas, more and more domestic Chinese medicine companies are also accelerating the expansion of the international market through marketing localization
.
For example, Tongrentang Sinopharm, a subsidiary of Tongrentang, has 69 retail terminals covering major countries and regions in Asia, Oceania, North America, and Europe
.
The Baiyun Mountain Huatuozaizao pill has also been sold or registered in 29 countries and territories on six continents, including Russia, Belarus, Ukraine, Georgia, Canada, Ecuador, New Zealand, Thailand and Vietnam
.
The industry believes that these products have accelerated and successfully launched in overseas markets, marking a key breakthrough in the internationalization of Chinese medicine, and Chinese medicine companies have entered the international market
.
However, it should be noted that the industry has also pointed out that with the steady progress of the internationalization of Chinese medicine, there are still many difficulties to be solved
.
For example, China’s current intellectual property legal system is far from meeting the need for protection of intellectual rights in traditional Chinese medicine, and is causing the loss of a large number of intellectual property rights, traditional knowledge and biological resources in traditional Chinese medicine.
.
In addition, in many countries, the clinical application of TCM has not yet obtained a real license.
For example, after some Chinese patent medicines go to the sea, they can only be placed on the shelves of health care products or food additives, and they cannot obtain the identity of medicines
.
In this regard, analysts suggest that in the process of promoting the international development of Chinese medicine, the exchange of talents and the promotion of appropriate technologies should also be strengthened, through the joint training model, so that Chinese medicine talents can be localized in the target country; and joint research projects, Start with botanicals and realize the localization of medicines in target countries
.
In addition, international cooperation can be further promoted by establishing overseas centers, strengthening the promotion of Chinese medicine culture, strengthening scientific research exchanges, establishing dialogue mechanisms, etc.
, and taking multiple measures to gradually deepen overseas recognition and acceptance of Chinese medicine, so as to continuously improve.
The overseas voice of Chinese medicine
.
In general, more and more overseas countries have a substantial increase in the recognition of Chinese medicine.
Although there are still some problems, in the future, domestic Chinese medicine companies and Chinese medicine exchanges and cooperation platforms will continue to expand and have more exchanges.
Under the background of channels, the industry generally believes that traditional Chinese medicine will certainly have huge room for development in overseas markets
.
